Advertisement
Screener

VERACYTE, INC. (VCYT) ROI

VERACYTE, INC. ROI

Return on investment (ROI), also called return on invested capital, is the profit a company earns for every dollar of long-term capital from both lenders and shareholders, shown as a percentage. It is net income divided by long-term debt plus shareholder equity, and the table shows both amounts. Because debt is included in the base, ROI does not rise just because a company replaces equity with borrowing, which sets it apart from ROE. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.

  • VERACYTE, INC. roi for fiscal 2021 was -6.88%, a change of 1.39% from fiscal 2020.
  • VERACYTE, INC. roi for fiscal 2020 was -8.27%, a change of -3.03% from fiscal 2019.
  • VERACYTE, INC. roi for fiscal 2019 was -5.25%, a change of 16.65% from fiscal 2018.
  • VERACYTE, INC. roi for fiscal 2018 was -21.90%.
Available history
2018-12-31 to 2021-12-31
Data captured

Historical ROI

DateROINet income 12 monthNet income 3 monthDebt plus equity
2021-12-31-6.88%-$75.56M-$10.56M$1.1B
2020-12-31-8.27%-$34.91M-$8.04M$422.04M

Annual ROI

DateROINet income 12 monthDebt plus equity
2021-12-31-6.88%-$75.56M$1.1B
2020-12-31-8.27%-$34.91M$422.04M
2019-12-31-5.25%-$12.6M$240.15M
2018-12-31-21.90%-$23M$105.04M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Celcuity Inc. (CELC)United States$3.887B-22.62
CareDx, Inc. (CDNA)United States$3.174B13.21
GRAIL, Inc. (GRAL)United States$5.591B-7.78
RadNet, Inc. (RDNT)United States$5.611B-229.65
Fortrea Holdings Inc. (FTRE)United States$1.903B-19.43
Personalis, Inc. (PSNL)United States$1.769B-13.30
CASTLE BIOSCIENCES INC (CSTL)United States$1.074B-37.45
Lumexa Imaging Holdings, Inc. (LMRI)United States$0.951B
Fulgent Genetics, Inc. (FLGT)United States$0.593B-6.70
BIODESIX INC (BDSX)United States$0.312B